RenovoRx Announces Closing of $12.1 Million Underwritten Public Offering of Common Stock
Financing led by new fundamental healthcare institutional investors February 11, 2025 07:00 AM Eastern Standard Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology…